Amphotericin B liposomal polyethylene glycol

Drug Profile

Amphotericin B liposomal polyethylene glycol

Alternative Names: Amphotericin B liposomal-PEG; Amphotericin B-PEG; PEG amphotericin B; PEG amphotericin B liposomal

Latest Information Update: 21 Jun 2001

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class Antifungals; Macrolides
  • Mechanism of Action Cell membrane permeability enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Mycoses

Most Recent Events

  • 21 Jun 2001 No-Development-Reported for Mycoses in Netherlands (Unknown route)
  • 30 Dec 1997 New profile
  • 30 Dec 1997 Preclinical development for Mycoses in Netherlands (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top